Novartis Investigative Site

Lugo 27880

0 studies enrolling now · 5 studies all time

What they study most

Alport Syndrome, Breast Cancer, Carcinoma, Renal Cell, Diabetic Kidney Disease, Diabetic Nephropathy Type 2, Focal Segmental Glomerulosclerosis, IgA Nephropathy, Immunoglobulin A Nephropathy, Neoplasms, Breast

Studies at this site

• Atrasentan in Patients With Proteinuric Glomerular Diseases — Running, not enrolling
• A Study of Zigakibart in Adults With IgA Nephropathy — Running, not enrolling
• ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D — Completed
• Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast Cancer — Completed
• Observational Study of Real World Effectiveness Data and Safety in Patients Receiving Pazopanib With Advanced or Metastatic Renal Cell Carcinoma — Completed